Mary E Temple

705 total citations
23 papers, 509 citations indexed

About

Mary E Temple is a scholar working on Infectious Diseases, Epidemiology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mary E Temple has authored 23 papers receiving a total of 509 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 8 papers in Epidemiology and 4 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mary E Temple's work include HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Mary E Temple is often cited by papers focused on HIV/AIDS drug development and treatment (5 papers), HIV Research and Treatment (3 papers) and Pneumocystis jirovecii pneumonia detection and treatment (3 papers). Mary E Temple collaborates with scholars based in United States and India. Mary E Temple's co-authors include Milap C. Nahata, Aileen B Luzier, David J. Kazierad, Katalin Korányi, Renee Robinson, John R. Hayes, A. Marc Harrison, Janet R. Reid, Stuart C. Morrison and Susana Arrigain and has published in prestigious journals such as Journal of the American Geriatrics Society, Drug Safety and Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy.

In The Last Decade

Mary E Temple

22 papers receiving 474 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mary E Temple United States	12	125	103	103	87	78	23	509
Saroj Khatiwada Nepal	16	16 0.1×	133 1.3×	24 0.2×	101 1.2×	85 1.1×	44	820
Geoffrey Omuse Kenya	15	20 0.2×	141 1.4×	76 0.7×	180 2.1×	41 0.5×	41	621
Susan Torrey United States	14	9 0.1×	58 0.6×	44 0.4×	110 1.3×	102 1.3×	27	637
Thomas Dobbs United States	14	109 0.9×	75 0.7×	115 1.1×	133 1.5×	28 0.4×	40	608
Sharmeen Gettner United States	10	38 0.3×	87 0.8×	88 0.9×	74 0.9×	5 0.1×	12	753
Raymond C. Bartlett United States	17	14 0.1×	297 2.9×	29 0.3×	321 3.7×	103 1.3×	57	942
Ronica M. Kluge United States	12	17 0.1×	193 1.9×	33 0.3×	146 1.7×	18 0.2×	20	544
Rosario Amaya‐Villar Spain	19	37 0.3×	597 5.8×	43 0.4×	283 3.3×	25 0.3×	46	1.7k
W. John Spicer Australia	13	10 0.1×	107 1.0×	21 0.2×	145 1.7×	34 0.4×	34	469
Robert Janknegt Netherlands	13	6 0.0×	223 2.2×	28 0.3×	248 2.9×	96 1.2×	48	817

Countries citing papers authored by Mary E Temple

Since Specialization

Citations

This map shows the geographic impact of Mary E Temple's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E Temple with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E Temple more than expected).

Fields of papers citing papers by Mary E Temple

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E Temple. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E Temple. The network helps show where Mary E Temple may publish in the future.

Co-authorship network of co-authors of Mary E Temple

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E Temple. A scholar is included among the top collaborators of Mary E Temple based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E Temple. Mary E Temple is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Temple, Mary E, et al.. (2014). Streamlining the residency interview process using Web-based teleconferencing. American Journal of Health-System Pharmacy. 71(9). 697–701. 12 indexed citations

Temple, Mary E, et al.. (2013). Implementation of a training program to improve pharmacy services for high-risk neonatal and maternal populations. American Journal of Health-System Pharmacy. 70(2). 143–149. 4 indexed citations

Harrison, A. Marc, Steve Davis, Janet R. Reid, et al.. (2005). Neonates with hypoplastic left heart syndrome have ultrasound evidence of abnormal superior mesenteric artery perfusion before and after modified Norwood procedure. Pediatric Critical Care Medicine. 6(4). 445–447. 45 indexed citations

Temple, Mary E, et al.. (2004). Frequency and Preventability of Adverse Drug Reactions in Paediatric Patients. Drug Safety. 27(11). 819–829. 62 indexed citations

Temple, Mary E, Katalin Korányi, & Milap C. Nahata. (2003). Lipodystrophy in HIV-Infected Pediatric Patients Receiving Protease Inhibitors. Annals of Pharmacotherapy. 37(9). 1214–1218. 13 indexed citations

Shermock, Kenneth M., Mary E Temple, & Zobair M. Younossi. (2002). The cost-effectiveness of treating chronic hepatitis C. 14. 34–40.

Shermock, Kenneth M., Mary E Temple, & Zobair M. Younossi. (2001). A pharmacoeconomic appraisal of therapies for hepatitis B and C. Expert Opinion on Pharmacotherapy. 2(2). 205–211. 2 indexed citations

Temple, Mary E, Michael T. Brady, Katalin Korányi, & Milap C. Nahata. (2001). Periorbital Cellulitis Secondary to Conidiobolus incongruus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(3). 351–354. 17 indexed citations

Temple, Mary E, Katalin Korányi, & Milap C. Nahata. (2001). The Safety and Antiviral Effect of Protease Inhibitors in Children. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 21(3). 287–294. 10 indexed citations

10.

Temple, Mary E, Katalin Korányi, & Milap C. Nahata. (2001). Gastrostomy Tube Placement in Nonadherent HIV-Infected Children. Annals of Pharmacotherapy. 35. 414–418. 1 indexed citations

11.

Temple, Mary E, Katalin Korányi, & Milap C. Nahata. (2001). Gastrostomy Tube Placement in Nonadherent HIV-Infected Children. Annals of Pharmacotherapy. 35(4). 414–418. 15 indexed citations

12.

Temple, Mary E & Milap C. Nahata. (2000). Pharmacotherapy of Lower Limb Diabetic Ulcers. Journal of the American Geriatrics Society. 48(7). 822–828. 15 indexed citations

13.

Temple, Mary E & Milap C. Nahata. (2000). Treatment of Listeriosis. Annals of Pharmacotherapy. 34(5). 656–661. 146 indexed citations

14.

Temple, Mary E & Milap C. Nahata. (2000). Treatment of Pediatric Hypertension. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 20(2). 140–150. 22 indexed citations

15.

Temple, Mary E & Milap C. Nahata. (2000). Pharmacotherapy of acute sinusitis in children. American Journal of Health-System Pharmacy. 57(7). 663–668. 8 indexed citations

16.

Temple, Mary E, Aileen B Luzier, & David J. Kazierad. (2000). Homocysteine as a Risk Factor for Atherosclerosis. Annals of Pharmacotherapy. 34. 57–65. 8 indexed citations

17.

Temple, Mary E, Milap C. Nahata, & Katalin Korányi. (1999). Pharmacotherapy of Tinea Capitis. The Journal of the American Board of Family Medicine. 12(3). 236–242. 2 indexed citations

18.

Temple, Mary E & Milap C. Nahata. (1999). Rifapentine: Its Role in the Treatment of Tuberculosis. Annals of Pharmacotherapy. 33(11). 1203–1210. 36 indexed citations

19.

Temple, Mary E & Milap C. Nahata. (1999). Interaction between Ciprofloxacin and Rifampin. Annals of Pharmacotherapy. 33(7-8). 868–870. 8 indexed citations

20.

Temple, Mary E, et al.. (1999). Tetravalent Rotavirus Vaccine. Annals of Pharmacotherapy. 33(7-8). 833–839. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact